In This Section
- News by Topic
- Media Resources
- University Events
- 5K Race for Humanity
- Advances in Pharmacy Practice
- Alumni Reunion Weekend
- Delivering Medication Therapy Management Services Certificate Program
- Discover Series
- Family Fall Fest
- Founders’ Day
- Graduate Student Orientation
- Healthy Lifestyles Social Media Business Competition
- Lois K. Cohen Lecture Series
- Making the Connections
- The Bernard J. Malis Memorial Lectureship in Humanities
- Misher Festival of Fine Arts and Humanities
- MLK Day of Service
- Patricia Leahy Memorial Lecture
- Pharmacy-Based Immunization Delivery Training
- Philadelphia Grain Malt Symposium
- Philadelphia Science Festival
- REEP Annual Symposium and Networking Event
- Research Day and John C. Krantz Jr. Lecture
- Undergraduate Research Festival
- Vestibular Rehabilitation Continuing Education Series
- Welcome Week
- USciences in the News
- The Bulletin Alumni Magazine
- The Insider Newsletter Signup
USciences and Franklin BioScience, a Leading Medical Cannabis Innovator, Announce Collaboration
USciences and Franklin BioScience announce a collaboration to help strengthen and enrich education, research, training and employment opportunities in the maturing multibillion-dollar cannabis sector in the US.
“This partnership will enrich the healthcare community’s understanding of cannabis by bringing together USciences’ strength in healthcare research and education with Franklin BioScience’s expertise and knowledge of developing innovative and trusted, scientifically supported medical cannabis products,” said Andrew Peterson, PharmD, PhD'09, John Wyeth Dean of Mayes College of Healthcare Business and Policy at USciences.
“We are honored to work with such a respected healthcare visionary like the USciences to help empower healthcare professionals with the knowledge they need to provide cutting-edge services,” said Jeremy Kahn, CEO of Franklin BioScience. “Excellence in research, science, and innovation is core to our mission. We believe that the healthcare community should and must play a vital role in the cannabis industry's growth and legitimization. We look forward to helping broaden healthcare providers’ and our partners’ understanding of the cannabis plant and better educating healthcare professionals on how safe, third-party tested and high-quality medical cannabis products can be used as a reliable medical alternative to treat a variety of patient conditions, and look forward to working with more healthcare leaders and pioneers now and in the future.”
The USciences-Franklin BioScience collaboration will include the development of educational programming focused on preparing students to understand the cannabis plant and its medicinal value. It will also provide a valuable research partnership. The organizations will actively work to develop a host of co-branded and mutually accessible curriculum and materials -- created with oversight by the USciences experts and faculty with input harvested from Franklin BioScience’s firsthand expertise researching, working, and innovating with the cannabis plant -- to help best educate physicians, healthcare professionals, and other interested parties.
This association also builds on the work of the Substance Use Disorders Institute at USciences (SUDI), which is an approved educational provider for the Pennsylvania Department of Health, Office of Medical Marijuana. SUDI offers the state mandated medical cannabis certification coursesfor healthcare providers and those interested in working with medical cannabis in Pennsylvania, one of the country’s next medical cannabis states set to come online in January 2018.
Franklin BioScience will expand its cultivation, manufacturing and dispensary operations, which span across Colorado and Nevada (two states where both medical and adult-use cannabis are legal). In the New Year, Franklin BioScience will also begin to serve patients at multiple dispensaries in Southeastern PA.
In 2017, the North American cannabis marketplace will grow 33 percent to nearly $10 billion. And with California and Canada coming online soon, adult-use markets will push the 2021 market to over $24 billion, according to Arcview Market Research. The latest Gallup poll also shows growing support for cannabis legalization with 64 percent of Americans now in favor of the measure. To date, the industry has also created over one-hundred thousand well-paying jobs across the country.
About Franklin BioScience
Franklin BioScience, the manufacturer of Altus products, operates in the legal cannabis sector that is changing lives for the better by providing patients and consumers with safe access to the highest-quality, consistent and precise cannabis products. Backed by a team of experts, Ph.D.'s, master cultivators and producers for science and precision, Franklin BioScience’s companies and brands research, develop and bring to market only the cleanest, safest, consistent and innovative cannabis products for the health, wellness and lifestyle marketplaces. The Franklin BioScience team is setting a new standard for best-in-class operating procedures, quality control, professionalism, testing methodologies and manufacturing and agricultural practices in the cannabis industry.
Categories: News, Academics, Research, Mayes College, Department of Health Policy, Health Policy, Public Health, Department of Pharmaceutical and Healthcare Business, Pharmaceutical and Healthcare Business, Substance Use Disorders Institute